Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Nov 22, 2021 8:46pm
135 Views
Post# 34155183

Todays House Positions

Todays House Positions
House Positions for C:ARCH from 20211122 to 20211122
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 17,200 74,408 4.326 0   17,200 -74,408
89 Raymond James 4,400 18,904 4.296 0   4,400 -18,904
85 Scotia 7,106 30,870 4.344 3,000 13,006 4.335 4,106 -17,864
2 RBC 5,977 25,736 4.306 2,087 9,077 4.349 3,890 -16,659
9 BMO Nesbitt 3,196 13,719 4.293 1,300 5,632 4.332 1,896 -8,087
80 National Bank 1,931 8,321 4.309 129 552 4.279 1,802 -7,769
124 Questrade 2,000 8,620 4.31 200 858 4.29 1,800 -7,762
53 Morgan Stanley 660 2,838 4.30 0   660 -2,838
79 CIBC 2,400 10,327 4.303 1,875 8,104 4.322 525 -2,223
14 ITG 51 218 4.275 136 588 4.324 -85 370
84 Ind Trading 0   128 550 4.297 -128 550
68 Leede 300 1,284 4.28 1,279 5,484 4.288 -979 4,200
13 Instinet 500 2,165 4.33 3,700 15,866 4.288 -3,200 13,701
7 TD Sec 4,153 18,088 4.355 18,825 81,043 4.305 -14,672 62,955
1 Anonymous 21,585 92,810 4.30 38,800 167,551 4.318 -17,215 74,741
TOTAL 71,459 308,308 4.314 71,459 308,311 4.315 0 3

<< Previous
Bullboard Posts
Next >>